Skip to search formSkip to main contentSkip to account menu

Rifamycins

Known as: Rifamycin, Rifamycins [Chemical/Ingredient], 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-B)furan-1,11(2h)-dione 21-Acetate 
A natural antibiotic produced by Streptomyces mediterranei, Rifamycin (Ansamycin Family) is a commonly used antimycobacterial drug that inhibits… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
SUMMARY Escherichia coli sequence type 131 (ST131) and Klebsiella pneumoniae ST258 emerged in the 2000s as important human… 
Review
2009
Review
2009
This report updates and combines earlier versions of guidelines for the prevention and treatment of opportunistic infections (OIs… 
Review
2008
Review
2008
Extended-spectrum beta-lactamases (ESBLs) represent a major threat among resistant bacterial isolates. The first types described… 
Review
2004
Review
2004
The discovery that Helicobacter pylori infection is the main cause of most gastroduodenal diseases has been a major breakthrough… 
Highly Cited
2002
Highly Cited
2002
Nine clinical isolates of Enterobacteriaceae (six Escherichia coli and three Proteus mirabilis) isolated in three Parisian… 
Review
2001
Review
2001
The rifamycin antibacterials, rifampicin (rifampin), rifabutin and rifapentine, are uniquely potent in the treatment of patients… 
Review
1998
Review
1998
Knowledge of the molecular genetic basis of resistance to antituberculous agents has advanced rapidly since we reviewed this… 
Highly Cited
1994
Highly Cited
1994
Highly Cited
1974
Highly Cited
1974